MedPath

Local application of Shukti bhasma to stop haemorrhage

Not yet recruiting
Conditions
Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism. Ayurveda Condition: RAKTASRAVAH,
Registration Number
CTRI/2025/05/087256
Lead Sponsor
DMM Ayurved Mahavidyalaya,Yavatmal
Brief Summary

This study is randomized trail comparing the efficacy and safety of shukti bhsasma and haemocoagulase  solution for haemostasis of capillary and venous haemorrhage in 35 patients of each group that will be conducted in India.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria
  • 1.The patients have any external capillary or venous haemorrhage from wounds resulting due to surgery or trauma on the whole body 2.Patients with ongoing antiplatelet or anticoagulant therapy like aspirin, clopidogrel, warfarin and heparin will also be included.
  • 3.Patients irrespective of gender, religion, marital status and socioeconomic class will be selected 4.Patients who will give their consent to participate.
Exclusion Criteria
  • The patients pre-diagnosed with bleeding disorders such as Haemophilia or Von Willebrand disease, sickle cell disease, anaemia (Hb less than 8gm), thrombocytopenia, who require BT, who have just received BT.
  • who need emergency surgical care and shock will be excluded.
  • Patients with arterial bleeding or associated arterial bleeding.
  • Patients with other systemic diseases such as AIDS, HBsAg, TB, Uncon trolled Diabetes, Uncontrolled Hypertension, Malignancy, Leprosy and STDs. 4.
  • Dagdha Vrana.
  • Ulcers with no bleeding.
  • Patients with wounds due to any animal or insect bite.
  • Pregnant and lactating mother.
  • Patients with addictions specifically alcohol, tobacco & smoking.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The clotting time will be noted after the dusting of Shukti Bhasma a 2mm thickevery minute for the first 10 min then | every 2 min for the next 10 min & then every 5 min till 30 min after 1hr, 6hrs, | 24hrs, 48hrs. After 48hrs if there is no bleeding follow-up will be taken after 1 | week.
layer over the bleeding site.every minute for the first 10 min then | every 2 min for the next 10 min & then every 5 min till 30 min after 1hr, 6hrs, | 24hrs, 48hrs. After 48hrs if there is no bleeding follow-up will be taken after 1 | week.
Secondary Outcome Measures
NameTimeMethod
Apart from haemostasis, other effects like discolouration, burning, tingling and warmth at the site of bleeding will be assessed.

Trial Locations

Locations (1)

Dayabhai Maoji Majithiya Ayurved Mahavidyalaya and L.K.Ayurved Rugnalaya,Yavatmal

🇮🇳

Yavatmal, MAHARASHTRA, India

Dayabhai Maoji Majithiya Ayurved Mahavidyalaya and L.K.Ayurved Rugnalaya,Yavatmal
🇮🇳Yavatmal, MAHARASHTRA, India
Dr Bhushan Baliram Kasbe
Principal investigator
9158166627
princebhushan358@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.